Andros Pharmaceuticals Co.,Ltd (TPEX:6917)
Taiwan · Delayed Price · Currency is TWD 40.80
+6.95 (20.53%)
Apr 20, 2026, 1:24 PM CST
TPEX:6917 Market Cap
TPEX:6917 has a market cap or net worth of 1.85 billion as of April 20, 2026. Its market cap has increased by 117.08% in one year.
Market Cap
1.85B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
40.80
Market Cap Chart
Since January 12, 2023, TPEX:6917's market cap has increased from 1.11B to 1.85B, an increase of 65.96%. That is a compound annual growth rate of 16.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 1.85B | 67.49% |
| Dec 31, 2025 | 1.10B | 43.17% |
| Dec 31, 2024 | 770.08M | -30.92% |
| Dec 29, 2023 | 1.11B | 0.19% |
| Jan 12, 2023 | 1.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3D Global Biotech | 2.48B |
| G&E Herbal Biotechnology | 2.38B |
| Chunghwa Chemical Synthesis & Biotech | 2.26B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.16B |
| Sunny Pharmtech | 2.13B |
| Synbio Tech | 2.04B |
| TaiRx | 1.99B |
| Anti-Microbial Savior BioteQ | 1.82B |